semaglutide articles SELECT Trial Semaglutide as a Cornerstone Therapy

Memon RA, Tecott LH, Nonogaki K, Beigneux A, Moser AH, Grunfeld C, Feingold KR

Foundayo (orforglipron) : Newly approved, Foundayo offers unmatched convenience as it can be taken at any time, without any food restrictions, and results in 12.4% weight loss

Always discuss new medications with your provider before starting, especially if you take other medications or have underlying GI conditions

Based on my age and health, whats the probability that this medicine will extend my life

Clinical trials cite average weight loss of 15 to 20 percent when semaglutide is combined with lifestyle adjustments

For the obesity treatment group, there was a 6.7% NAION incidence for patients taking semaglutide compared to a 0.8% incidence rate for patients taking other medications for weight loss